DexCom (DXCM) operating income was $912M in FY2025 (+52% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2025
$912M
+52%
2024
$600M
+0%
2023
$598M
+53%
2022
$391M
+47%
2021
$266M
-11%
2020
$300M
+99%
2019
$150M
+181%
2018
-$186M
-338%
2017
-$42M
+33%
2016
-$64M
-12%
2015
-$57M
-166%
2014
-$22M
+26%
2013
-$29M
+48%
2012
-$56M
-24%
2011
-$45M
+1%
2010
-$45M
+2%
2009
-$46M
Recent Quarterly Operating Income
Quarter
Operating Income
Q1 2026
$255M
Q4 2025
$323M
Q3 2025
$242M
Q2 2025
$213M
Q1 2025
$134M
Q4 2024
$189M
Q3 2024
$152M
Q2 2024
$158M
Q1 2024
$101M
Q4 2023
$217M
Q3 2023
$206M
Q2 2023
$128M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.